Ac3 GlcNAcproN3
| Product Name | Ac3 GlcNAcproN3 |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-52038 |
| CAS No. | 595568-98-2 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 430.41 g/mol |
| Mol. For. | C17H26N4O9 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
L-Xylonic acid | GD1bsph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GD3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT2sph d18:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Carrageenan | GD1aCer d20:1/12:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Lewis Y (Le Y) | H-Antigen-Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GD2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GlcNAcb1, 3Galb1, 4GlcNAc | Lactose PEG-NH2 | GT1csph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | C24:1 β-Glucosylceramide | GM1asph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GQ3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GM2 | LewisxCer d18:1/18:0-Biotin (Galb1,4(Fuca1,3)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GalNAcproN3 | GM1bCer d18:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GT3Cer d18:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1aCer d18:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GT2sph d20:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | GD2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/24:1 (Neu5Aca2,3Galb1,4GlcbCeramide) | GD3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Sialyl-Lc4 | GD1aCer d20:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/8:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GQ3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GD2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1bCer d20:1/8:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GM3Cer d20:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GQ3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | SSEA-4 d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GD1asph d18:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1 | GD3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1bCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | iGloboH | GT3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2sph d20:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Lacto-N-difucohexaose | GD3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | nLc4 | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d18:1/18:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | iGB5Cer d18:1/18:0-Biotin (Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GD1aCer d18:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | LNnDFH II | Galc d18:1/18:0（GalaCeramide） | nLc4Cer d18:1/18:0-Biotin (Galb1,4GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GD1bsph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Gluconapin | GM3sph d18:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | NeuAca2, 6Galb1, 4GlcNAc | Lacto-N-difucohexaose II | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d18:1/24:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) |